Global Supply Chains in the Pharmaceutical Industry PDF Download

Author: Nozari, Hamed
Publisher: IGI Global
ISBN: 1522559221
Category : Business & Economics
Languages : en
Pages : 399

View

Book Description
In a rapidly growing global economy, where there is a constant emergence of new business models and dynamic changes to the business ecosystem, there is a need for the integration of traditional, new, and hybrid concepts in the complex structure of supply chain management. Within the fast-paced pharmaceutical industry, product strategy, life cycles, and distribution must maintain the highest level of agility. Therefore, organizations need strong supply chain capabilities to profitably compete in the marketplace. Global Supply Chains in the Pharmaceutical Industry provides innovative insights into the efforts needed to build and maintain a strong supply chain network in order to achieve efficient fulfillment of demand, drive outstanding customer value, enhance organizational responsiveness, and build network resiliency. This publication is designed for supply chain managers, policymakers, researchers, academicians, and students, and covers topics centered on economic cycles, sustainable development, and new forces in the global economy.

Author: Fred A. Kuglin
Publisher: CRC Press
ISBN: 1040084907
Category : Business & Economics
Languages : en
Pages : 125

View

Book Description
Error-proofing in the production process of pharmaceuticals isn‘t just a matter of good business, it has life-and-death implications for consumers. To that end, the 2013 Drug Quality and Security Act in large part requires new mandates on tracking and tracing chain of custody in the supply chain. Pharmaceutical Supply Chain: Drug Quality and Securi

Author: Ana Paula Barbosa-Povoa
Publisher: Springer
ISBN: 3030153983
Category : Medical
Languages : en
Pages : 269

View

Book Description
This book provides an insight of relevant case studies and updated practices in “PharmaceuticalSupply Chains” (PharmSC) while addressing the most relevant topics within the COST Action “Medicines Shortages” (CA15105).The volume focuses on the most recent developments in the design, planning and scheduling ofPharmSC, broadening from the suppliers’ selection to the impact on patients and healthcaresystems, addressing uncertainty and risk mitigation, and computational issues. It is directed at MSc/PhD students and young researchers (Post-Docs) in Pharmaceutics/Pharmaceutical sciences, Engineering fields, Economics/Management, as well as pharmaceutical decision makers, managers, and practitioners, and advanced readers demanding a fresh approach to decision making for PharmSC. The contributed chapters are associated with the homonymous COST Training Schools (TS), and the book creates a better understanding of the Action “Medicines Shortages” challenges and opportunities.

Author: Hedley Rees
Publisher: John Wiley & Sons
ISBN: 0470922842
Category : Medical
Languages : en
Pages : 458

View

Book Description
This book bridges the gap between practitioners of supply-chain management and pharmaceutical industry experts. It aims to help both these groups understand the different worlds they live in and how to jointly contribute to meaningful improvements in supply-chains within the globally important pharmaceutical sector. Scientific and technical staff must work closely with supply-chain practitioners and other relevant parties to help secure responsive, cost effective and risk mitigated supply chains to compete on a world stage. This should not wait until a drug has been registered, but should start as early as possible in the development process and before registration or clinical trials. The author suggests that CMC (chemistry manufacturing controls) drug development must reset the line of sight – from supply of drug to the clinic and gaining a registration, to the building of a patient value stream. Capable processes and suppliers, streamlined logistics, flexible plant and equipment, shorter cycle times, effective flow of information and reduced waste. All these factors can and should be addressed at the CMC development stage.

Author: Robert Handfield
Publisher: CRC Press
ISBN: 1439899797
Category : Business & Economics
Languages : en
Pages : 254

View

Book Description
A comprehensive exploration of the massive changes in the biopharmaceutical supply chain that have occurred during the past 10 years, and predicted future trends, Biopharmaceutical Supply Chains: Distribution, Regulatory, Systems and Structural Changes Ahead documents the specific impacts of these changes for key players in the supply chain. Based

Author: Fred Kuglin
Publisher: CRC Press
ISBN: 1040080286
Category : Business & Economics
Languages : en
Pages : 112

View

Book Description
Technology alone does nothing for global companies. When applied to business processes in an effective way, new technologies can produce breakthrough changes in how companies conduct business. Using Technology to Transform the Value Chain demonstrates the need for using these emerging technologies in business to maintain competitiveness. This book illustrates how connectivity can enable a firm to make informed business choices and create new revenue streams while managing and maximizing connectivity. This text also presents case studies from a variety of industries to show how new technologies can be deployed in different business environments in order to enhance productivity and performance.

Author: Institute of Medicine
Publisher: National Academies Press
ISBN: 0309269393
Category : Medical
Languages : en
Pages : 377

View

Book Description
The adulteration and fraudulent manufacture of medicines is an old problem, vastly aggravated by modern manufacturing and trade. In the last decade, impotent antimicrobial drugs have compromised the treatment of many deadly diseases in poor countries. More recently, negligent production at a Massachusetts compounding pharmacy sickened hundreds of Americans. While the national drugs regulatory authority (hereafter, the regulatory authority) is responsible for the safety of a country's drug supply, no single country can entirely guarantee this today. The once common use of the term counterfeit to describe any drug that is not what it claims to be is at the heart of the argument. In a narrow, legal sense a counterfeit drug is one that infringes on a registered trademark. The lay meaning is much broader, including any drug made with intentional deceit. Some generic drug companies and civil society groups object to calling bad medicines counterfeit, seeing it as the deliberate conflation of public health and intellectual property concerns. Countering the Problem of Falsified and Substandard Drugs accepts the narrow meaning of counterfeit, and, because the nuances of trademark infringement must be dealt with by courts, case by case, the report does not discuss the problem of counterfeit medicines.

Author: Yao-Hua Tan
Publisher: Springer Science & Business Media
ISBN: 364215669X
Category : Business & Economics
Languages : en
Pages : 376

View

Book Description
One of the major challenges for European governments is to solve the dilemma of increasing the security and reducing fraud in international trade, while at the same time reducing the administrative burden for commercial as well as public administration organisations. To address these conflicting demands, the ITAIDE project has developed a large set of innovative IT-related tools and methods that enable companies to be better in control of their business operations. These tools and methods have been integrated in the ITAIDE Information Infrastructure (I3) framework. By using the I3 framework, companies are better positioned to apply for the Trusted Trader status, and enjoy trade facilitation benefits such as simplified customs procedures and fewer inspections of their goods. Hence, the I3 framework can contribute to making global supply chains faster, cheaper, and more secure. The I3 framework has been tested and validated in five real-life Living Labs, spanning four different sectors of industry, and conducted in five different EU countries. National Tax & Customs organizations from various European countries have actively participated in the Living Labs. The United Nations CEFACT group, experts from the World Customs Organization and representatives of key industry associations have also provided valuable feedback and ideas for the Living Labs and the project in general. www.itaide.org

Author: United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions
Publisher:
ISBN:
Category : Drug adulteration
Languages : en
Pages : 96

View

Book Description

Author: Jan Dethloff
Publisher: Springer
ISBN: 331913177X
Category : Technology & Engineering
Languages : en
Pages : 522

View

Book Description
This book gathers papers presented at the Logistik-Management-Konferenz 2013, which was organized by the VHB Wissenschaftliche Kommission Logistik and held in Bremen, Germany. The papers reflect the current state-of-the-art in logistics and supply chain management, focusing on environmental sustainability in logistics and supply chain network dynamics and control. The target audience primarily consists of researchers and practitioners in the field, but the book may also be beneficial for graduate students.